European Psychiatry - Volume 33 - March 2016

767 / 812

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805 S763
until August 2015. The luck of improvement led to her admission.
We stopped antipsychotic treatments and prescribed her vitamin E
(900mg/day), clonazepam (6mg/day) and vitamin B6. The follow-
up led to the decline of the Abnormal Involuntary Movement Scale
(AIMS) score of 7 points over 6 weeks.
Conclusion TD remains a serious side effect that worsens the
prognosis and affects the quality of life of patients. Cluster
randomised trial should be done in order to develop practice rec-
ommendations for prevention and management of TD.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1298
A psychiatrist’s poll on their methods
to treat schizoaffective disorder
L. Aguado ∗, B. Girela , P. Calvo , J.E. Mu˜noz-Negro ,
J.A. Cervilla
1 San Cecilio University Hospital, Metal Health Unit, Granada, Spain
2 Santa Ana Hospital, Mental Health Unit, Motril, Spain
∗ Corresponding author.
Introduction Schizoaffective disorder (SAD) is the second most
frequent psychotic disorder after schizophrenia. There is a relative
scarcity of specific studies looking into SAD treatment and evidence
on drug treatment of SAD is patchy. We aimed to study naturalisti-
cally, interviewing psychiatrists systematically, what do they think
is most useful in SAD treatment.
Objectives/aims To know the actual management of SAD in real
clinical practice and provided data for effective clinical studies.
Methods We administered an online poll to 65 psychiatrists (52%
male, 48% female), 75% of which described themselves as having a
holistic background. The poll was completed using a Google doc’s
questionnaire. The three main questions made were:
– what is your first treatment choice for SAD;
– do you tend to use mono- vs. poly-therapy;
– provide a level of utility for each drug between 1 (little use) to 4
(maximum use).
Results Atypical antipsychotics were considered the most com-
mon first choice in the treatment of SAD according to 66.2% of
psychiatrists. The second most selected first choice answer was
combining drugs and psychotherapy, which was answered by 20%
of the sample. Monotherapy was preferred (60%) to polytherapy
(40%). Finally, the most useful drug for SAD according to the sam-
ple was aripiprazole followed by mood stabilizers, olanzapine and
paliperidone.
Conclusions Real practice in SAD treatment may differ grossly to
what is advocated for in clinical guidelines and seem to also deviate
from officially approved indications of some drugs.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1299
Erotomania: A case and review
A. Almada ∗ uengo , P. Casquinha , M.J. Heitor
Hospital Beatriz Ângelo, Psychiatry, Loures, Portugal
∗ Corresponding author.
Introduction Erotomania (“Clérambault’s syndrome”) is a rare
syndrome characterized by a delusional belief of being loved by
another person, usually of higher social status.
Objective This case report aims to describe and discuss a case of
erotomania, providing an updated review on this disorder.
Methods Regular clinical interviews were performed during
admission period to collect information about the clinical case and
to promote an intervention approach to the patient. A literature
review in Science Direct database, with the keyword “erotomania”,
was also conducted.
Results A 51-year-old woman was admitted in Beatriz Ângelo
Hospital psychiatric ward with delusional beliefs of being loved
by the ex-boss. Positive misperceptions and persecutory delusions
regarding her husband as the obstacle for the love were mani-
fested. The lack of insight for the situation and the necessity of
treatment created some difficulties. A clinical report and a biblio-
graphic review were made to allow a better understanding about
the case and to orient the case evidence based.
Conclusions Despite the evidence about the good response of
atypical antipsychotics (e.g. risperidone) in erotomania, in our case
study, the partial remission was only achieved with high dose of
the old typical antipsychotic, pimozide.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1300
Defining therapeutic plans and
purposes for psychiatric patients
served by a home-visiting program
F. Couto Gomes∗, G. Sobreira , I. Capeto Coelho , J. Oliveira
Centro Hospitalar Psiquiátrico de Lisboa, Psychiatry, Lisbon, Portugal
∗ Corresponding author.
Introduction PreTrarCa is a home-visiting program at an in-
patient clinic in Lisbon, Portugal, constituted by a team of nurses,
social workers and a psychologist, and managed by a psychiatrist.
Objective To describe the criteria and purposes for the home-
visiting program, its congruence with therapeutic plans, and
patients’ service satisfaction.
Aims To help in defining common purposes to patients and pro-
fessionals, to improve quality of care.
Methods Questionnaires regarding admission criteria and pur-
poses for the home-visiting, individualized therapeutic plans and
service satisfactionwere applied to patients, family, teammembers
and psychiatrists.
Results As for the individual treatment plan, symptom con-
trol and better treatment adherence were frequently mentioned
by patients, family members, team members and psychiatrists
(respectively, 72.22% and 47.22%, 93.75% and 93.75%, 94,44% and
91.67%, and 68.42% and 33.33%). Team members frequently men-
tioned control of drug adverse effects (88.89%) and psychiatrists
frequently mentioned control of drug adverse effects, social inte-
gration and social skills (42.11%, 36.84%, 21.05%). As for the
purposes of home-visiting, symptom control and better treatment
adherence/administration of long acting injectable drugs were fre-
quently mentioned by the majority of patients, family members,
team members and psychiatrists (69.44% and 66.67%, 93.75% and
93.75%, 91.67% and 80.55%, 52.63% and 68.42%).
Conclusions Patients, families, team members and psychiatrists
share similar views on the individual therapeutic plans, though
team members and psychiatrists give importance to some aspects
that patients and their families tend not to mention. Purposes are
generally congruent with treatment plans, which may signal satis-
factory communication between all these elements.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.